ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Glucagon- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Published Date: August 2025
|
Report Code: QYRE-Auto-19M646
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Glucagon Market Insights and Forecast to 2028
BUY CHAPTERS

Glucagon- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Code: QYRE-Auto-19M646
Report
August 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Taj Pharmaceuticals
Xeris Pharmaceuticals

Glucagon- Market Size

The global market for Glucagon was estimated to be worth US$ 625 million in 2024 and is forecast to a readjusted size of US$ 941 million by 2031 with a CAGR of 6.1% during the forecast period 2025-2031.

Glucagon- Market

Glucagon- Market

Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.
Global Glucagon main players are Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, etc. Global top four manufacturers hold a share over 80%. North America is the largest market, with a share nearly 40%.
This report aims to provide a comprehensive presentation of the global market for Glucagon, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Glucagon by region & country, by Type, and by Application.
The Glucagon market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glucagon.
Market Segmentation

Scope of Glucagon- Market Report

Report Metric Details
Report Name Glucagon- Market
Forecasted market size in 2031 US$ 941 million
CAGR 6.1%
Forecasted years 2025 - 2031
Segment by Type
  • Inject Glucagon
  • Nasal Glucagon
Segment by Application
  • Emergency Kits
  • General Use
  • Diagnostic & Motility
  • Cardiogenic Shock
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, Taj Pharmaceuticals, Xeris Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Glucagon manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Glucagon in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Glucagon in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Glucagon- Market size in 2031?

Ans: The Glucagon- Market size in 2031 will be US$ 941 million.

What is the market share of major companies in Glucagon- Market?

Ans: Global top four manufacturers hold a share over 80%.

What is the Glucagon- Market share by region?

Ans: North America is the largest market, with a share nearly 40%.

Who are the main players in the Glucagon- Market report?

Ans: The main players in the Glucagon- Market are Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, Taj Pharmaceuticals, Xeris Pharmaceuticals

What are the Application segmentation covered in the Glucagon- Market report?

Ans: The Applications covered in the Glucagon- Market report are Emergency Kits, General Use, Diagnostic & Motility, Cardiogenic Shock, Others

What are the Type segmentation covered in the Glucagon- Market report?

Ans: The Types covered in the Glucagon- Market report are Inject Glucagon, Nasal Glucagon

1 Market Overview
1.1 Glucagon Product Introduction
1.2 Global Glucagon Market Size Forecast
1.2.1 Global Glucagon Sales Value (2020-2031)
1.2.2 Global Glucagon Sales Volume (2020-2031)
1.2.3 Global Glucagon Sales Price (2020-2031)
1.3 Glucagon Market Trends & Drivers
1.3.1 Glucagon Industry Trends
1.3.2 Glucagon Market Drivers & Opportunity
1.3.3 Glucagon Market Challenges
1.3.4 Glucagon Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Glucagon Players Revenue Ranking (2024)
2.2 Global Glucagon Revenue by Company (2020-2025)
2.3 Global Glucagon Players Sales Volume Ranking (2024)
2.4 Global Glucagon Sales Volume by Company Players (2020-2025)
2.5 Global Glucagon Average Price by Company (2020-2025)
2.6 Key Manufacturers Glucagon Manufacturing Base and Headquarters
2.7 Key Manufacturers Glucagon Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Glucagon
2.9 Glucagon Market Competitive Analysis
2.9.1 Glucagon Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Glucagon Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glucagon as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Inject Glucagon
3.1.2 Nasal Glucagon
3.2 Global Glucagon Sales Value by Type
3.2.1 Global Glucagon Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Glucagon Sales Value, by Type (2020-2031)
3.2.3 Global Glucagon Sales Value, by Type (%) (2020-2031)
3.3 Global Glucagon Sales Volume by Type
3.3.1 Global Glucagon Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Glucagon Sales Volume, by Type (2020-2031)
3.3.3 Global Glucagon Sales Volume, by Type (%) (2020-2031)
3.4 Global Glucagon Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Emergency Kits
4.1.2 General Use
4.1.3 Diagnostic & Motility
4.1.4 Cardiogenic Shock
4.1.5 Others
4.2 Global Glucagon Sales Value by Application
4.2.1 Global Glucagon Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Glucagon Sales Value, by Application (2020-2031)
4.2.3 Global Glucagon Sales Value, by Application (%) (2020-2031)
4.3 Global Glucagon Sales Volume by Application
4.3.1 Global Glucagon Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Glucagon Sales Volume, by Application (2020-2031)
4.3.3 Global Glucagon Sales Volume, by Application (%) (2020-2031)
4.4 Global Glucagon Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Glucagon Sales Value by Region
5.1.1 Global Glucagon Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Glucagon Sales Value by Region (2020-2025)
5.1.3 Global Glucagon Sales Value by Region (2026-2031)
5.1.4 Global Glucagon Sales Value by Region (%), (2020-2031)
5.2 Global Glucagon Sales Volume by Region
5.2.1 Global Glucagon Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Glucagon Sales Volume by Region (2020-2025)
5.2.3 Global Glucagon Sales Volume by Region (2026-2031)
5.2.4 Global Glucagon Sales Volume by Region (%), (2020-2031)
5.3 Global Glucagon Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Glucagon Sales Value, 2020-2031
5.4.2 North America Glucagon Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Glucagon Sales Value, 2020-2031
5.5.2 Europe Glucagon Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Glucagon Sales Value, 2020-2031
5.6.2 Asia Pacific Glucagon Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Glucagon Sales Value, 2020-2031
5.7.2 South America Glucagon Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Glucagon Sales Value, 2020-2031
5.8.2 Middle East & Africa Glucagon Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Glucagon Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Glucagon Sales Value
6.2.1 Key Countries/Regions Glucagon Sales Value, 2020-2031
6.2.2 Key Countries/Regions Glucagon Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Glucagon Sales Value, 2020-2031
6.3.2 United States Glucagon Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Glucagon Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Glucagon Sales Value, 2020-2031
6.4.2 Europe Glucagon Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Glucagon Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Glucagon Sales Value, 2020-2031
6.5.2 China Glucagon Sales Value by Type (%), 2024 VS 2031
6.5.3 China Glucagon Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Glucagon Sales Value, 2020-2031
6.6.2 Japan Glucagon Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Glucagon Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Glucagon Sales Value, 2020-2031
6.7.2 South Korea Glucagon Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Glucagon Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Glucagon Sales Value, 2020-2031
6.8.2 Southeast Asia Glucagon Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Glucagon Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Glucagon Sales Value, 2020-2031
6.9.2 India Glucagon Sales Value by Type (%), 2024 VS 2031
6.9.3 India Glucagon Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Novo Nordisk
7.1.1 Novo Nordisk Company Information
7.1.2 Novo Nordisk Introduction and Business Overview
7.1.3 Novo Nordisk Glucagon Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Novo Nordisk Glucagon Product Offerings
7.1.5 Novo Nordisk Recent Development
7.2 Eli Lilly
7.2.1 Eli Lilly Company Information
7.2.2 Eli Lilly Introduction and Business Overview
7.2.3 Eli Lilly Glucagon Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Eli Lilly Glucagon Product Offerings
7.2.5 Eli Lilly Recent Development
7.3 Fresenius Kabi
7.3.1 Fresenius Kabi Company Information
7.3.2 Fresenius Kabi Introduction and Business Overview
7.3.3 Fresenius Kabi Glucagon Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Fresenius Kabi Glucagon Product Offerings
7.3.5 Fresenius Kabi Recent Development
7.4 Torrent Labs
7.4.1 Torrent Labs Company Information
7.4.2 Torrent Labs Introduction and Business Overview
7.4.3 Torrent Labs Glucagon Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Torrent Labs Glucagon Product Offerings
7.4.5 Torrent Labs Recent Development
7.5 Taj Pharmaceuticals
7.5.1 Taj Pharmaceuticals Company Information
7.5.2 Taj Pharmaceuticals Introduction and Business Overview
7.5.3 Taj Pharmaceuticals Glucagon Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Taj Pharmaceuticals Glucagon Product Offerings
7.5.5 Taj Pharmaceuticals Recent Development
7.6 Xeris Pharmaceuticals
7.6.1 Xeris Pharmaceuticals Company Information
7.6.2 Xeris Pharmaceuticals Introduction and Business Overview
7.6.3 Xeris Pharmaceuticals Glucagon Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Xeris Pharmaceuticals Glucagon Product Offerings
7.6.5 Xeris Pharmaceuticals Recent Development
8 Industry Chain Analysis
8.1 Glucagon Industrial Chain
8.2 Glucagon Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Glucagon Sales Model
8.5.2 Sales Channel
8.5.3 Glucagon Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
FEATURED COMPANIES
Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Taj Pharmaceuticals
Xeris Pharmaceuticals
List of Tables
 Table 1. Glucagon Market Trends
 Table 2. Glucagon Market Drivers & Opportunity
 Table 3. Glucagon Market Challenges
 Table 4. Glucagon Market Restraints
 Table 5. Global Glucagon Revenue by Company (2020-2025) & (US$ Million)
 Table 6. Global Glucagon Revenue Market Share by Company (2020-2025)
 Table 7. Global Glucagon Sales Volume by Company (2020-2025) & (K MT)
 Table 8. Global Glucagon Sales Volume Market Share by Company (2020-2025)
 Table 9. Global Market Glucagon Price by Company (2020-2025) & (USD/MT)
 Table 10. Key Manufacturers Glucagon Manufacturing Base and Headquarters
 Table 11. Key Manufacturers Glucagon Product Type
 Table 12. Key Manufacturers Time to Begin Mass Production of Glucagon
 Table 13. Global Glucagon Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glucagon as of 2024)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Glucagon Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Glucagon Sales Value by Type (2020-2025) & (US$ Million)
 Table 18. Global Glucagon Sales Value by Type (2026-2031) & (US$ Million)
 Table 19. Global Glucagon Sales Market Share in Value by Type (2020-2025)
 Table 20. Global Glucagon Sales Market Share in Value by Type (2026-2031)
 Table 21. Global Glucagon Sales Volume by Type: 2020 VS 2024 VS 2031 (K MT)
 Table 22. Global Glucagon Sales Volume by Type (2020-2025) & (K MT)
 Table 23. Global Glucagon Sales Volume by Type (2026-2031) & (K MT)
 Table 24. Global Glucagon Sales Market Share in Volume by Type (2020-2025)
 Table 25. Global Glucagon Sales Market Share in Volume by Type (2026-2031)
 Table 26. Global Glucagon Price by Type (2020-2025) & (USD/MT)
 Table 27. Global Glucagon Price by Type (2026-2031) & (USD/MT)
 Table 28. Global Glucagon Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
 Table 29. Global Glucagon Sales Value by Application (2020-2025) & (US$ Million)
 Table 30. Global Glucagon Sales Value by Application (2026-2031) & (US$ Million)
 Table 31. Global Glucagon Sales Market Share in Value by Application (2020-2025)
 Table 32. Global Glucagon Sales Market Share in Value by Application (2026-2031)
 Table 33. Global Glucagon Sales Volume by Application: 2020 VS 2024 VS 2031 (K MT)
 Table 34. Global Glucagon Sales Volume by Application (2020-2025) & (K MT)
 Table 35. Global Glucagon Sales Volume by Application (2026-2031) & (K MT)
 Table 36. Global Glucagon Sales Market Share in Volume by Application (2020-2025)
 Table 37. Global Glucagon Sales Market Share in Volume by Application (2026-2031)
 Table 38. Global Glucagon Price by Application (2020-2025) & (USD/MT)
 Table 39. Global Glucagon Price by Application (2026-2031) & (USD/MT)
 Table 40. Global Glucagon Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
 Table 41. Global Glucagon Sales Value by Region (2020-2025) & (US$ Million)
 Table 42. Global Glucagon Sales Value by Region (2026-2031) & (US$ Million)
 Table 43. Global Glucagon Sales Value by Region (2020-2025) & (%)
 Table 44. Global Glucagon Sales Value by Region (2026-2031) & (%)
 Table 45. Global Glucagon Sales Volume by Region (K MT): 2020 VS 2024 VS 2031
 Table 46. Global Glucagon Sales Volume by Region (2020-2025) & (K MT)
 Table 47. Global Glucagon Sales Volume by Region (2026-2031) & (K MT)
 Table 48. Global Glucagon Sales Volume by Region (2020-2025) & (%)
 Table 49. Global Glucagon Sales Volume by Region (2026-2031) & (%)
 Table 50. Global Glucagon Average Price by Region (2020-2025) & (USD/MT)
 Table 51. Global Glucagon Average Price by Region (2026-2031) & (USD/MT)
 Table 52. Key Countries/Regions Glucagon Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
 Table 53. Key Countries/Regions Glucagon Sales Value, (2020-2025) & (US$ Million)
 Table 54. Key Countries/Regions Glucagon Sales Value, (2026-2031) & (US$ Million)
 Table 55. Key Countries/Regions Glucagon Sales Volume, (2020-2025) & (K MT)
 Table 56. Key Countries/Regions Glucagon Sales Volume, (2026-2031) & (K MT)
 Table 57. Novo Nordisk Company Information
 Table 58. Novo Nordisk Introduction and Business Overview
 Table 59. Novo Nordisk Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 60. Novo Nordisk Glucagon Product Offerings
 Table 61. Novo Nordisk Recent Development
 Table 62. Eli Lilly Company Information
 Table 63. Eli Lilly Introduction and Business Overview
 Table 64. Eli Lilly Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 65. Eli Lilly Glucagon Product Offerings
 Table 66. Eli Lilly Recent Development
 Table 67. Fresenius Kabi Company Information
 Table 68. Fresenius Kabi Introduction and Business Overview
 Table 69. Fresenius Kabi Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 70. Fresenius Kabi Glucagon Product Offerings
 Table 71. Fresenius Kabi Recent Development
 Table 72. Torrent Labs Company Information
 Table 73. Torrent Labs Introduction and Business Overview
 Table 74. Torrent Labs Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 75. Torrent Labs Glucagon Product Offerings
 Table 76. Torrent Labs Recent Development
 Table 77. Taj Pharmaceuticals Company Information
 Table 78. Taj Pharmaceuticals Introduction and Business Overview
 Table 79. Taj Pharmaceuticals Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 80. Taj Pharmaceuticals Glucagon Product Offerings
 Table 81. Taj Pharmaceuticals Recent Development
 Table 82. Xeris Pharmaceuticals Company Information
 Table 83. Xeris Pharmaceuticals Introduction and Business Overview
 Table 84. Xeris Pharmaceuticals Glucagon Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
 Table 85. Xeris Pharmaceuticals Glucagon Product Offerings
 Table 86. Xeris Pharmaceuticals Recent Development
 Table 87. Key Raw Materials Lists
 Table 88. Raw Materials Key Suppliers Lists
 Table 89. Glucagon Downstream Customers
 Table 90. Glucagon Distributors List
 Table 91. Research Programs/Design for This Report
 Table 92. Key Data Information from Secondary Sources
 Table 93. Key Data Information from Primary Sources


List of Figures
 Figure 1. Glucagon Product Picture
 Figure 2. Global Glucagon Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Glucagon Sales Value (2020-2031) & (US$ Million)
 Figure 4. Global Glucagon Sales Volume (2020-2031) & (K MT)
 Figure 5. Global Glucagon Sales Price (2020-2031) & (USD/MT)
 Figure 6. Glucagon Report Years Considered
 Figure 7. Global Glucagon Players Revenue Ranking (2024) & (US$ Million)
 Figure 8. Global Glucagon Players Sales Volume Ranking (2024) & (K MT)
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Glucagon Revenue in 2024
 Figure 10. Glucagon Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 11. Inject Glucagon Picture
 Figure 12. Nasal Glucagon Picture
 Figure 13. Global Glucagon Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 14. Global Glucagon Sales Value Market Share by Type, 2024 & 2031
 Figure 15. Global Glucagon Sales Volume by Type (2020 VS 2024 VS 2031) & (K MT)
 Figure 16. Global Glucagon Sales Volume Market Share by Type, 2024 & 2031
 Figure 17. Global Glucagon Price by Type (2020-2031) & (USD/MT)
 Figure 18. Product Picture of Emergency Kits
 Figure 19. Product Picture of General Use
 Figure 20. Product Picture of Diagnostic & Motility
 Figure 21. Product Picture of Cardiogenic Shock
 Figure 22. Product Picture of Others
 Figure 23. Global Glucagon Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 24. Global Glucagon Sales Value Market Share by Application, 2024 & 2031
 Figure 25. Global Glucagon Sales Volume by Application (2020 VS 2024 VS 2031) & (K MT)
 Figure 26. Global Glucagon Sales Volume Market Share by Application, 2024 & 2031
 Figure 27. Global Glucagon Price by Application (2020-2031) & (USD/MT)
 Figure 28. North America Glucagon Sales Value (2020-2031) & (US$ Million)
 Figure 29. North America Glucagon Sales Value by Country (%), 2024 VS 2031
 Figure 30. Europe Glucagon Sales Value, (2020-2031) & (US$ Million)
 Figure 31. Europe Glucagon Sales Value by Country (%), 2024 VS 2031
 Figure 32. Asia Pacific Glucagon Sales Value, (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Glucagon Sales Value by Region (%), 2024 VS 2031
 Figure 34. South America Glucagon Sales Value, (2020-2031) & (US$ Million)
 Figure 35. South America Glucagon Sales Value by Country (%), 2024 VS 2031
 Figure 36. Middle East & Africa Glucagon Sales Value, (2020-2031) & (US$ Million)
 Figure 37. Middle East & Africa Glucagon Sales Value by Country (%), 2024 VS 2031
 Figure 38. Key Countries/Regions Glucagon Sales Value (%), (2020-2031)
 Figure 39. Key Countries/Regions Glucagon Sales Volume (%), (2020-2031)
 Figure 40. United States Glucagon Sales Value, (2020-2031) & (US$ Million)
 Figure 41. United States Glucagon Sales Value by Type (%), 2024 VS 2031
 Figure 42. United States Glucagon Sales Value by Application (%), 2024 VS 2031
 Figure 43. Europe Glucagon Sales Value, (2020-2031) & (US$ Million)
 Figure 44. Europe Glucagon Sales Value by Type (%), 2024 VS 2031
 Figure 45. Europe Glucagon Sales Value by Application (%), 2024 VS 2031
 Figure 46. China Glucagon Sales Value, (2020-2031) & (US$ Million)
 Figure 47. China Glucagon Sales Value by Type (%), 2024 VS 2031
 Figure 48. China Glucagon Sales Value by Application (%), 2024 VS 2031
 Figure 49. Japan Glucagon Sales Value, (2020-2031) & (US$ Million)
 Figure 50. Japan Glucagon Sales Value by Type (%), 2024 VS 2031
 Figure 51. Japan Glucagon Sales Value by Application (%), 2024 VS 2031
 Figure 52. South Korea Glucagon Sales Value, (2020-2031) & (US$ Million)
 Figure 53. South Korea Glucagon Sales Value by Type (%), 2024 VS 2031
 Figure 54. South Korea Glucagon Sales Value by Application (%), 2024 VS 2031
 Figure 55. Southeast Asia Glucagon Sales Value, (2020-2031) & (US$ Million)
 Figure 56. Southeast Asia Glucagon Sales Value by Type (%), 2024 VS 2031
 Figure 57. Southeast Asia Glucagon Sales Value by Application (%), 2024 VS 2031
 Figure 58. India Glucagon Sales Value, (2020-2031) & (US$ Million)
 Figure 59. India Glucagon Sales Value by Type (%), 2024 VS 2031
 Figure 60. India Glucagon Sales Value by Application (%), 2024 VS 2031
 Figure 61. Glucagon Industrial Chain
 Figure 62. Glucagon Manufacturing Cost Structure
 Figure 63. Channels of Distribution (Direct Sales, and Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Insulin Biologics and Biosimilars Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global GLP 1 Weight Loss Drug Market Research Report 2024
Global Hormonal Therapy for Type 2 Diabetes Market Research Report 2024
Global GLP 1 Peptide Drugs Market Research Report 2024
Global Medication for Diabetes Market Research Report 2024
Global GLP 1 based Therapy Market Research Report 2024
Global GLP 1 Injection Market Research Report 2024
Global GLP 1 Drug Peptide API Market Research Report 2024
Global Type 2 Diabetes Medications Market Research Report 2024
Global GLP 1RA Therapy Market Research Report 2024
Global Mealtime Insulin Market Research Report 2024
Global Hypoglycemic Drugs Market Insights Forecast to 2030
Glucagon Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Glucagon Injection Market Research Report 2025
GLP 1 for Diabetes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Dulaglutide Market Research Report 2024
GLP 1 Analogues Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Somatostatin Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Diabetes Drug Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Peptide Drugs for Diabetes Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions